The global asthma inhaler device market is expected to expand at a robust CAGR of 4.1% during the forecast period, between 2021 and 2028. Asthma refers to a condition where the airways narrow and swell up, producing extra mucus. This makes breathing difficult and triggers coughing and wheezing as a result of shortness of breath. If the asthma condition is major, it can result in a life-threatening asthma attack. To treat asthma and overcome the shortness of breath, inhaling devices are provided to asthma patients. These inhaler devices quickly deliver the medicines into the airways, thus curing the shortness of breath, temporarily. Inhaler devices are required to be carried by asthma patients everywhere and must be used again, which is why they required to be cleaned regularly and well maintained.
Market Trends, Drivers, Restraints, and Opportunities:
- Rising prevalence of asthma in the population primarily drives the market.
- Rapid urbanization and industrialization indirectly result in air pollution, which is the main cause of asthma. This, in turn, fueling the market growth.
- Development in the medical and healthcare industry has stemmed the integration of advanced medications, including better quality inhalers, spurring the market growth.
- Technical problems with inhalers and the side effects caused by these devices can hamper the market growth.
- Increasing awareness, drug launches, and technological advancements are a few factors that are expected to provide lucrative opportunities for market growth.
Scope of the report:
The report on the global asthma inhaler device market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.
| Attributes | Details |
| Report Title | Asthma Inhaler Device Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast |
| Base Year | 2020 |
| Historic Data | 2018 & 2019 |
| Forecast Period | 2021–2028 |
| Segmentation | Types (Metered Dose Inhalers, Dry Powder Inhalers, and Soft Mist Inhalers), Modes of Operations (Manually Operated Inhaler Devices and Digitally-operated Inhaler Devices), End-users (Hospitals & Clinics and Homecare) |
| Regional Scope | Asia Pacific, North America, Europe, Latin America, and Middle East & Africa |
| Report Coverage | Market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities, and revenue forecast |
Asthma Inhaler Device Market Segment Insights:
Metered dose inhaler segment is projected to hold significant market share
Based on types, the asthma inhaler device market can be categorized as metered dose inhalers, dry powder inhalers, and soft mist inhalers. The metered dose inhalers are a preferred choice of inhaler devices due to their importance in the treatment of chronic lung diseases, including asthma. Metered dose inhalers have a variety of medicines which are contained in a pressurised canister, in a plastic case with a mouthpiece. This device has a holding chamber comprising a plastic tube with a mouthpiece, a valve that controls mist delivery, and a soft sealed end that holds the inhaler. The holding chamber mainly administers the delivery of the medicine into the lungs of the patient.
Advancement in technology can drive the digitally operated inhaler segment
On the basis of modes of operations, the market can be bifurcated into manually operated inhaler devices and digitally-operated inhaler devices. The integration of the digitally operated inhaler devices was marked as a significant milestone as it facilitates the asthma patients to have a better understanding of inhaler usages through digital technologies. Digital inhalers have built in sensors that detect the inhaler use and ascertain inspiratory flow, according to the release. This data is sent to the smart phones of the users and doctors to review over time. This new technology makes it a hassle-free treatment option that further drives the market segment.
Hospitals & clinics segment held substantial market share in 2020
In terms of end-users, the market can be segmented into hospitals & clinics and homecare. The rising presence of healthcare centers and the availability of medical service at hospitals has driven the hospitals & clinics segment. Increasing number of skilled doctors and medical staff in hospitals that provide efficient and accurate diagnosis and treatment has shifted preference toward this market segment.
North America to account a major market share
Based on regions, the global asthma inhaler device market can be segregated into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America constituted a significant share of the market in 2020 due to rising prevalence of asthma in the region. Moreover, increase in R&D spending by medical and pharmaceutical companies and growing healthcare infrastructure in the US are driving the market in North America. The market in Asia Pacific is projected to expand at a significant CAGR during the forecast period due to growing R&D expenditure and government initiatives in the healthcare industry.
Segments
By Types
- Metered Dose Inhalers
- Dry Powder Inhalers
- Soft Mist Inhalers
By Modes of Operation
- Manually Operated Inhaler Devices
- Digitally-oerated Inhaler Devices
By End-users
- Hospitals & Clinics
- Homecare
By Regions
- North America
- Europe
- Latin America
- Asia Pacific
- Middle East & Africa
Competitive Landscape
Key players in the global asthma inhaler device market include Aerogen Inc., AstraZeneca PLC, Baxter International Inc., Boehringer Ingelheim International GmbH, 3M COMPANY, GF Health Products, GlaxoSmithKline Plc, Koninklijke Philips N.V., Novartis AG, PARI medical Holding GMBH, and Smith’s Group Plc. These players engage in mergers & acquisitions, collaborations, agreements, and partnerships to strengthen their geographical presence.
Request For Customization
Enquiry Before Buying
Speak With Analyst
